Division of Clinical Epidemiology Lady Davis InstituteJewish General HospitalMcGill University Montreal QC Canada.
Department of Medicine McGill University Montreal QC Canada.
J Am Heart Assoc. 2021 Sep 21;10(18):e021686. doi: 10.1161/JAHA.121.021686. Epub 2021 Sep 6.
Radiation therapy demonstrates a clear survival benefit in the treatment of several malignancies. However, cancer survivors can develop a wide array of cardiotoxic complications related to radiation. This pathology is often underrecognized by clinicians and there is little known on how to manage this population. Radiation causes fibrosis of all components of the heart and significantly increases the risk of coronary artery disease, cardiomyopathy, valvulopathy, arrhythmias, and pericardial disease. Physicians should treat other cardiovascular risk factors aggressively in this population and guidelines suggest obtaining regular imaging once symptomatology is established. Patients with radiation-induced cardiovascular disease tend to do worse than their traditional counterparts for the same interventions. However, there is a trend toward fewer complications and lower mortality with catheter-based rather than surgical approaches, likely because radiation makes these patients poor surgical candidates. When appropriate, these patients should be referred for percutaneous management of valvulopathy and coronary disease.
放射治疗在治疗多种恶性肿瘤方面显示出明确的生存获益。然而,癌症幸存者可能会出现多种与放射相关的心脏毒性并发症。这种病理通常被临床医生所忽视,对于如何管理这一人群知之甚少。放射会导致心脏的所有成分纤维化,并显著增加冠状动脉疾病、心肌病、瓣膜病、心律失常和心包疾病的风险。在这一人群中,医生应该积极治疗其他心血管危险因素,指南建议一旦出现症状就应定期进行影像学检查。患有放射性心血管疾病的患者在接受相同干预措施时的预后比传统患者差。然而,与手术方法相比,导管介入方法的并发症更少,死亡率更低,这可能是因为放射使这些患者成为手术的不良候选者。在适当的情况下,这些患者应被转诊接受经皮瓣膜病和冠状动脉疾病的治疗。